Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER

CEFUROXIME SODIUM

Standard Dose
EQ 750MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER is listed in Drugs@FDA under application 050780 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFUROXIME SODIUM Form and strength INJECTABLE;INJECTION - EQ 750MG BASE/VIAL Sponsor B BRAUN Submission history Latest submission status date: 2020-12-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER is listed in Drugs@FDA under application 050780 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFUROXIME SODIUM Form and strength INJECTABLE;INJECTION - EQ 750MG BASE/VIAL Sponsor B BRAUN Submission history Latest submission status date: 2020-12-05 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER (CEFUROXIME SODIUM) | Drug Monograph | MedicHelpline